Mental health outcomes of a pilot 2-arm randomized controlled trial of a HIV-prevention program for South African adolescent girls and young women and their female caregivers

Table 3 Differences in depression and post-traumatic stress disorder (PTSD) symptoms between treatment groups at follow-up

	Intervention group		Control group		Crude estimate	95% CI	p value	Adjusted estimate^a	95% CI	p value
	Baseline (n = 30)	Follow-up (n = 28)	Baseline (n = 30)	Follow-up (n = 24)	Crude estimate	95% CI	p value	Adjusted estimate^a	95% CI	p value
Depression
No symptoms (scores of 0)	1 (3.3%)	11 (39.3%)	3 (10.0%)	4 (16.7%)	1			1
Symptoms of depression (scores of 1–9)	17 (56.7%)	13 (46.4%)	21 (70.0%)	16 (66.7%)	0.30	(0.08, 1.14)	0.08	0.22	(0.05, 0.95)	0.04
Positive screen for depression (scores of 10+)^b	12 (40.0%)	4 (14.3%)	6 (20.0%)	4 (16.7%)	0.36	(0.06, 2.19)	0.27	0.17	(0.02, 1.52)	0.12
PTSD
No symptoms (scores of 0)	15 (50.0%)	22 (78.6%)	17 (56.7%)	18 (75.0%)	1			1
Symptoms of PTSD (scores of 1–5)	15 (50.0%)	6 (21.4%)	13 (43.3%)	6 (25.0%)	0.82	(0.22, 2.98)	0.76	0.85	(0.21, 3.27)	0.81

Estimates are relative risk ratios (RRRs) for depression and odds ratios (ORs) for PTSD
^aAdjusted estimates control for the outcome at baseline
^bScore range is 0–27 at baseline and 0–24 at follow-up since one item assessing suicidal thoughts was removed from the follow-up survey

ISSN: 1471-2458